AdaptHealth (AHCO) Projected to Post Quarterly Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO - Get Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect AdaptHealth to post earnings of $0.25 per share and revenue of $829.19 million for the quarter. Individual that wish to register for the company's earnings conference call can do so using this link.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO traded down $0.29 during trading hours on Friday, reaching $8.48. 1,363,088 shares of the stock were exchanged, compared to its average volume of 939,103. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of -5.14, a P/E/G ratio of 1.15 and a beta of 1.12. The stock's fifty day simple moving average is $9.85 and its 200 day simple moving average is $10.18. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth has a 52 week low of $7.16 and a 52 week high of $11.90.

Analyst Ratings Changes

Several research analysts have weighed in on AHCO shares. Canaccord Genuity Group lowered their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Wednesday, November 6th. Truist Financial dropped their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, November 15th. UBS Group decreased their target price on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Royal Bank of Canada lowered their target price on shares of AdaptHealth from $13.00 to $11.00 and set an "outperform" rating on the stock in a report on Tuesday, November 19th. Finally, Robert W. Baird cut their price target on AdaptHealth from $16.00 to $14.00 and set an "outperform" rating for the company in a research note on Wednesday, November 6th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $12.20.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.